Abiomed Inc. (NASDAQ: ABMD) was started with a Buy rating and assigned a $195 price target at SunTrust Robinson Humphrey. Jefferies reiterated its Buy rating on Abiomed and raised its target to $208 from $175, talking up its opportunities.
Albemarle Corp. (NYSE: ALB) was started with a Buy rating and assigned a $150 price target (versus a $132.32 close) at Loop Capital.
BRT Apartments Corp. (NYSE: BRT) was started with a Neutral rating and assigned a $10.50 fair value target (versus a $10.36 close) at Janney.
Centene Corp. (NYSE: CTC) was reiterated as Outperform and the price target was raised to $105 from $95 at Oppenheimer.
Conn’s Inc. (NASDAQ: CONN) was raised to Outperform from Perform with a $40 price target (versus a $25.65 close) at Oppenheimer. The firm noted that credit fixes are giving way to a substantial earnings recovery. Conn’s was indicated up almost 15% at $29.44 on Friday.
DCT Industrial Trust Inc. (NYSE: DCT) was started as Neutral and assigned a $59 fair value target at Janney.
First Industrial Realty Trust Inc. (NYSE: FR) was started with a Buy rating and assigned a $34 fair value target at Janney.
FMC Corp. (NYSE: FMC) was started with a Buy rating and assigned a $102 price target at Loop Capital.
Goldcorp Inc. (NYSE: GG) was raised to Buy from Hold at Canaccord Genuity.
Government Properties Income Trust (NYSE: GOV) was started with a Neutral rating and was given a $20 price target at D.A. Davidson.
Heartland Express Inc. (NASDAQ: HTLD) was raised to Buy from Hold with a $29 price target (versus a $23.30 close) at Stifel.
IAMGOLD Corp. (NYSE: IAG) was downgraded to Hold from Buy at Canaccord Genuity.
Ingevity Corp. (NYSE: NGVT) was started as Buy and assigned a $73 price target at Loop Capital.
J.B. Hunt Transport Services Inc. (NASDAQ: JBHT) was raised to Buy from Hold with a $125 price target (versus a $108.90 close) at Stifel.
Mastercard Inc. (NYSE: MA) was started as Overweight with a $165 price target (versus $139.67 close) at Cantor Fitzgerald.
Trinity Industries Inc. (NYSE: TRN) was raised to Buy from Neutral with a $36 price target (versus a $31.18 close) at Citigroup. While this has been considered a boring value stock for some time, this upgrade was actually the day after Trinity hit a 52-week high of $31.32 and shares were indicated up 1.4% at $31.63 on Friday.
Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) was up 52% at $9.44 on Thursday after positive study results in patients with a rare developmental disorder called fragile X syndrome. Zynerba was raised to Overweight from Neutral at Piper Jaffray. Oppenheimer maintained a Perform rating, noting that its FXS study results were informative but also noted that the program is not without risks.
Thursday’s top analyst calls included ADM, BlackRock, DexCom, Mallinckrodt, McDonald’s, Philip Morris, Redfin and about two dozen more.